| Literature DB >> 23221787 |
Andrew D Zelenetz1, William G Wierda, Jeremy S Abramson, Ranjana H Advani, C Babis Andreadis, Nancy Bartlett, Naresh Bellam, John C Byrd, Myron S Czuczman, Luis Fayad, Martha J Glenn, Jon P Gockerman, Leo I Gordon, Nancy Lee Harris, Richard T Hoppe, Steven M Horwitz, Christopher R Kelsey, Youn H Kim, Susan Krivacic, Ann S LaCasce, Auayporn Nademanee, Pierluigi Porcu, Oliver Press, Barbara Pro, Nishitha Reddy, Lubomir Sokol, Lode Swinnen, Christina Tsien, Julie M Vose, Joachim Yahalom, Nadeem Zafar, Maoko Naganuma, Mary A Dwyer.
Abstract
These NCCN Guidelines Insights summarize several key updates to the 2012 NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Hodgkin's Lymphomas (NHL) and describe the clinical evidence supporting the updates. The featured updates include changes to the recommendations for treatment options in patients with chronic lymphocytic leukemia (including in elderly or frail patients and patients with poor-risk cytogenetics), guidance surrounding surveillance imaging for follow-up of patients with NHL, and the addition of first-line consolidation options for patients with mantle cell lymphoma.Entities:
Mesh：
Year: 2012 PMID： 23221787 DOI： 10.6004/jnccn.2012.0155
Source DB: PubMed Journal: J Natl Compr Canc Netw ISSN： 1540-1405 Impact factor: 11.908